Universitäres Centrum für Tumorerkrankungen Mainz (UCT Mainz)
Klinisch orientierter Schwerpunkt / Johannes Gutenberg-Universität Mainz
Dargel, Christina; Bassani-Sternberg, Michal; Hasreiter, Julia et al.
T Cells Engineered to Express a T-Cell Receptor Specific for Glypican-3 to Recognize and Kill Hepatoma Cells In Vitro and in MiceGASTROENTEROLOGY. Bd. 149. H. 4. 2015 S. 1042-1052
Kang, Biao; Okwieka, Patricia; Schoettler, Susanne et al.
Tailoring the stealth properties of biocompatible polysaccharide nanocontainersBIOMATERIALS. Bd. 49. 2015 S. 125-134
Drube, Sebastian; Weber, Franziska; Goepfert, Christiane et al.
TAK1 and IKK2, novel mediators of SCF-induced signaling and potential targets for c-Kit-driven diseasesONCOTARGET. Bd. 6. H. 30. 2015 S. 28833-28850
Almstedt, Katrin; Schmidt, Marcus
Targeted Therapies Overcoming Endocrine Resistance in Hormone Receptor-Positive Breast CancerBREAST CARE. Bd. 10. H. 3. 2015 S. 168-172
Tomaszowski, Karl-Heinz; Aasland, Dorthe; Margison, Geoffrey P. et al.
The bacterial alkyltransferase-like (eATL) protein protects mammalian cells against methylating agent-induced toxicityDNA REPAIR. Bd. 28. 2015 S. 14-20
Deng, Shiwei; Yan, Tiandong; Nikolova, Teodora et al.
The catalytic topoisomerase II inhibitor dexrazoxane induces DNA breaks, ATF3 and the DNA damage response in cancer cellsBRITISH JOURNAL OF PHARMACOLOGY. Bd. 172. H. 9. 2015 S. 2246-2257
Petersen, Morten A.; Aaronson, Neil K.; Arraras, Juan I. et al.
The computer adaptive test (CAT) version of the EORTC QLQ-C30QUALITY OF LIFE RESEARCH. Bd. 24. 2015 S. 43-43
Roessler, Jessica; Ammerpohl, Ole; Gutwein, Jana et al.
The CpG island methylator phenotype in breast cancer is associated with the lobular subtypeEPIGENOMICS. Bd. 7. H. 2. 2015 S. 187-199
Finn, Richard S.; Crown, John P.; Lang, Istvan et al.
The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 studyLANCET ONCOLOGY. Bd. 16. H. 1. 2015 S. 25-35
Finn, Richard S.; Crown, John; Lang, Istvan et al.
The effect of palbociclib (P) in combination with letrozole (L) on bone metastases in women with ER+/HER2-metastatic breast cancer (MBC): Subanalysis from a randomized phase II study.JOURNAL OF CLINICAL ONCOLOGY. Bd. 33. H. 15. 2015